Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects.
Abstract | OBJECTIVE: METHODS AND SUBJECTS: Between 1996 and 1997, 1,335 subjects (620 men and 715 women) were recruited from one Japanese community, interviewed, and examined. Clinical measurements in the study included intimal-medial thickness (IMT) of the carotid artery, fasting plasma insulin, serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol ( LDL-C), fasting plasma glucose (FPG), hemoglobin type HbA1c, systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI). We divided the subjects of both genders into three subgroups according to age (40-49 years of age; 50-59; and 60-69). RESULTS: Using simple regression analysis, we found that IMT was significantly correlated with at least one of TC, LDL-C, HbA1c, SBP, DBP, and BMI in each subgroup. The results of multivariate analysis showed that IMT was independently correlated with TC, HDL-C, LDL-C, SBP and BMI in males and with TC, TG, HDL-C, LDL-C, HbA1c, SBP, DBP, and BMI in females. Insulin levels showed no correlation with IMT in either males or females. CONCLUSION:
|
Authors | M Okada, T Miida, H Hama, S Yata, T Sunaga, A Tsuda, H Saito |
Journal | Internal medicine (Tokyo, Japan)
(Intern Med)
Vol. 39
Issue 5
Pg. 362-8
(May 2000)
ISSN: 0918-2918 [Print] Japan |
PMID | 10830174
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cholesterol, HDL
- Cholesterol, LDL
- Glycated Hemoglobin A
- Insulin
- Cholesterol
|
Topics |
- Adult
- Aged
- Blood Pressure
- Body Mass Index
- Carotid Artery Diseases
(blood, etiology, prevention & control)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cholesterol, LDL
(blood)
- Female
- Glycated Hemoglobin
(metabolism)
- Humans
- Insulin
(blood)
- Japan
- Male
- Middle Aged
- Risk Factors
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|